miR ‑888 regulates cancer progression by targeting multiple targets in lung adenocarcinoma.

In conclusion, our findings indicated that miR‑888 may act as a potential new therapeutic target for patients with lung adenocarcinoma. PMID: 31002360 [PubMed - as supplied by publisher]
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research